More Policy News
-
NewsSHEA affirms trust in ACIP and supports science-based vaccine policy
Public health experts have commented on the removal by the US Department of Health and Human Services (HHS) of all 17 members of the Advisory Committee on Immunization Practices (ACIP), which advises the Centers for Disease Control and Prevention (CDC) on the use of vaccines in the US.
-
NewsAmericans say benefits of MMR vaccine for children outweigh risks by nearly 5-1
While many Americans know how measles can spread, most cannot accurately estimate the prevalence of complications associated with measles such as hospitalization or the risks it presents during pregnancy, according to a new survey.
-
NewsThe Global Fund to fight AIDS, Tuberculosis and Malaria ‘should step up efforts’
The international community must protect global responses to HIV, tuberculosis (TB), and malaria to serve humanity’s collective interests, according to a new opinion article.
-
NewsDisease experts call for reinstatement of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC)
The Society for Healthcare Epidemiology of America has called for the reinstatement of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC), warning that decades of progress in preventing healthcare-associated infections are under threat.
-
NewsNational-level actions effective at tackling antibiotic resistance
National-level policies can reduce the impact of antibiotic resistance across diverse countries, according to a new study. The comparison of countries found that national action was consistently associated with improved indicators of antibiotic resistance.
-
NewsThe beginning of the end: Setting a global target for rubella eradication
Scientists discuss the 2024 World Health Organization’s (WHO) recommendation for universal introduction of rubella-containing vaccines (RCVs) into childhood vaccination programs in all countries – particularly in the remaining 19 countries that have yet to do so.
-
NewsMicrobiologists must seize the day - and make their mark on policy
Microbiologists need to seize opportunities to engage with policymaking in order to move towards better, more scientifically informed policy that serves the common good, a new paper published in Sustainable Microbiology urges.
-
NewsSecurity-relevant research in times of geopolitical polarisation: report
A new report on security-relevant research - including research into pathogens - notes a change within the scientific system due to increased national security interests.
-
NewsWHO calls for urgent action to address worldwide disruptions in tuberculosis services
Since World Tuberculosis Day is only days away, World Health Organization addresses the current challenges faced by countries in TB responses. They urgently call for an united global effort to combat the deadly disease and safeguard the public health from the devastating consequences.
-
NewsProfessor Sabiha Essack wins Christiana Figueres Policy to Practice Award
Professor Sabiha Essack, the South African Research Chair in Antibiotic Resistance and One Health, Professor in Pharmaceutical Sciences at the University of KwaZulu-Natal, has been awarded the Christiana Figueres Policy to Practice Award.
-
NewsThe Institut Pasteur joins the Stand Up for Science community
Echoing the Stand Up for Science Day initiated in the United States, scientists and academics in France are calling for mobilization actions in every city.
-
NewsCambridge initiative to address risks of future engineered pandemics
Management strategies are initiated by University of Cambridge to address the challenges and preventive measures required in response to a potential engineered pandemic threat in the future.
-
NewsRising threat of carbapenem-resistant Enterobacteriales (CRE) spurs urgent healthcare alert
The deteriorating epidemiological situation of carbapenem-resistant Enterobacteriales (CRE) has spurred ECDC to alert EU/EAA countries to the importance of controlling the spread of CRE infections to safeguard their healthcare systems.
-
NewsExplainable deep learning model provides new understanding of harmful algal blooms in China’s lakes and reservoirs
Researchers have developed an advanced explainable deep learning model to predict and analyze harmful algal blooms (HABs) in freshwater lakes and reservoirs across China, offering insights into their underlying drivers and potential mitigation strategies.
-
NewsA Sustainable Development Goal for space?
Scientists have called for the designation of a new United Nations Sustainable Development Goal (SDG) with the aim to conserve and sustainably use Earth’s orbit, and prevent the accumulation of space junk.
-
NewsHarnessing AI to respond to the global threat of antimicrobial resistance
An international team of researchers has created an AI tool to bridge critical gaps in knowledge needed for informal policy development in AMR and to assist in the preparation of National Action Plans.
-
NewsUK needs to keep up momentum on cutting methane emissions, urges Lords Committee
Applied Microbiology International contributed to the House of Lords committee report that calls on the Government to keep up the momentum on cutting methane emissions at home, while using its scientific expertise to be more engaged in international leadership.
-
NewsIn a warming world, public needs to know more about protections from mosquito-borne illnesses
Very few (15%) among the American public worry that they or their families will contract dengue or West Nile virus over the new three months, according to the latest Annenberg Public Policy Center (APPC) health knowledge survey.
-
NewsPolicy change may be helping to drive rise in treatment-resistant vaginal thrush
A change in policy may be helping to drive a rise in treatment-resistant vaginal thrush, amid significant yearly increases in the prevalence of fungal infections caused by fungal Candida species, suggests the first study of its kind.
-
NewsEuropean capacity for antibiotic R&D requires long-term funding
The AMR Accelerator projects have called for long-term investments, stressing the need to preserve the European capacity for antibiotic R&D by sustaining the assets, expertise, and research infrastructures required to develop new treatments for drug-resistant infections.